Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
[S,S]-Reboxetine Long-term Study in Fibromyalgia
NCT00607256Phase 3Terminated
- Sponsor
- Pfizer
- Start
- Oct 2007
- Primary completion
- May 2009
- Modality
- Small Molecules
- Countries
- 11
01
Overview
A Phase 3 trial of reboxetine in fibromyalgia (FM), sponsored by Pfizer. Started Oct 2007; status: terminated.
02
Drugs
reboxetine
03
Conditions
fibromyalgia (FM)
Beyond the preview
Go deeper on NCT00607256.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00607256.